| Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in … AJ Ferrari, DF Santomauro, A Aali, YH Abate, C Abbafati, H Abbastabar, ... The Lancet 403 (10440), 2133-2161, 2024 | 487 | 2024 |
| Global burden of cardiovascular diseases and risks, 1990-2022 GA Mensah, V Fuster, CJL Murray, GA Roth, ... Journal of the American College of Cardiology 82 (25), 2350-2473, 2023 | 486 | 2023 |
| Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease … M Brauer, GA Roth, AY Aravkin, P Zheng, KH Abate, YH Abate, C Abbafati, ... The Lancet 403 (10440), 2162-2203, 2024 | 452 | 2024 |
| Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the … M Naghavi, KL Ong, A Aali, HS Ababneh, YH Abate, C Abbafati, ... The Lancet 403 (10440), 2100-2132, 2024 | 449 | 2024 |
| Global, regional, and national burden of disorders affecting the nervous system, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 JD Steinmetz, KM Seeher, N Schiess, E Nichols, B Cao, C Servili, ... The Lancet Neurology 23 (4), 344-381, 2024 | 439 | 2024 |
| Global burden of bacterial antimicrobial resistance 1990–2021: a systematic analysis with forecasts to 2050 M Naghavi, SE Vollset, KS Ikuta, LR Swetschinski, AP Gray, EE Wool, ... The Lancet 404 (10459), 1199-1226, 2024 | 307 | 2024 |
| Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950–2021, and the impact of the … AE Schumacher, HH Kyu, A Aali, C Abbafati, J Abbas, ... The Lancet 403 (10440), 1989-2056, 2024 | 296 | 2024 |
| Burden of disease scenarios for 204 countries and territories, 2022–2050: a forecasting analysis for the Global Burden of Disease Study 2021 SE Vollset, HS Ababneh, YH Abate, C Abbafati, R Abbasgholizadeh, ... The Lancet 403 (10440), 2204-2256, 2024 | 197 | 2024 |
| A systematic review and meta-analysis on chloroquine and hydroxychloroquine as monotherapy or combined with azithromycin in COVID-19 treatment RM Ghazy, A Almaghraby, R Shaaban, A Kamal, H Beshir, A Moursi, ... Scientific reports 10 (1), 22139, 2020 | 135 | 2020 |
| The burden of bacterial antimicrobial resistance in the WHO African region in 2019: a cross-country systematic analysis B Sartorius, AP Gray, ND Weaver, GR Aguilar, LR Swetschinski, KS Ikuta, ... The Lancet Global Health 12 (2), e201-e216, 2024 | 106 | 2024 |
| Global fertility in 204 countries and territories, 1950–2021, with forecasts to 2100: a comprehensive demographic analysis for the Global Burden of Disease Study 2021 NV Bhattacharjee, AE Schumacher, A Aali, YH Abate, R Abbasgholizadeh, ... The lancet 403 (10440), 2057-2099, 2024 | 89 | 2024 |
| Global, regional, and national burden of stroke and its risk factors, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 VL Feigin, MD Abate, YH Abate, S Abd ElHafeez, F Abd-Allah, ... The Lancet Neurology 23 (10), 973-1003, 2024 | 82 | 2024 |
| A systematic review and meta-analysis of the catastrophic costs incurred by tuberculosis patients RM Ghazy, HM El Saeh, S Abdulaziz, EA Hammouda, AM Elzorkany, ... Scientific Reports 12 (1), 558, 2022 | 78 | 2022 |
| COVID-19 vaccine booster dose acceptance: systematic review and meta-analysis SA Abdelmoneim, M Sallam, DM Hafez, E Elrewany, HM Mousli, ... Tropical medicine and infectious disease 7 (10), 298, 2022 | 74 | 2022 |
| Global, regional, and national burden of meningitis and its aetiologies, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 HY Wunrow, RG Bender, A Vongpradith, SB Sirota, LR Swetschinski, ... The Lancet Neurology 22 (8), 685-711, 2023 | 71 | 2023 |
| Efficacy and effectiveness of SARS-CoV-2 vaccines: a systematic review and meta-analysis RM Ghazy, R Ashmawy, NA Hamdy, YAM Elhadi, OA Reyad, ... Vaccines 10 (3), 350, 2022 | 68 | 2022 |
| The coronavirus disease 2019 (COVID-19) vaccination psychological antecedent assessment using the Arabic 5c validated tool: An online survey in 13 Arab countries MS Abdou, KA Kheirallah, MO Aly, A Ramadan, YAM Elhadi, I Elbarazi, ... PloS one 16 (11), e0260321, 2021 | 68 | 2021 |
| The role of psychological factors and vaccine conspiracy beliefs in influenza vaccine hesitancy and uptake among Jordanian healthcare workers during the COVID-19 pandemic M Sallam, RM Ghazy, K Al-Salahat, K Al-Mahzoum, NM AlHadidi, H Eid, ... Vaccines 10 (8), 1355, 2022 | 63 | 2022 |
| Acceptance of COVID-19 vaccine booster doses using the health belief model: a cross-sectional study in low-middle-and high-income countries of the East Mediterranean region RM Ghazy, MS Abdou, S Awaidy, M Sallam, I Elbarazi, N Youssef, ... International journal of environmental research and public health 19 (19), 12136, 2022 | 49 | 2022 |
| Arabic validation and cross-cultural adaptation of the 5C scale for assessment of COVID-19 vaccines psychological antecedents S Abd ElHafeez, I Elbarazi, R Shaaban, R ElMakhzangy, M Ossama Aly, ... PloS one 16 (8), e0254595, 2021 | 44 | 2021 |
Ramy ShaabanAssistant Professor - Utah State UniversityVerifierad e-postadress på usu.edu